is ketamine fda approved

The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

Since it was developed in 2016, we’ve blogged several times about esketamine—the isomer of ketamine being developed by Janssen Pharmaceuticals, designed to rapidly alleviate the symptoms of treatment-resistant depression. Esketamine, which will be administered intranasally, was granted breakthrough medication status by the FDA and fast-tracked for approval. And the time for approval is here.